NASDAQ:PCRX - Pacira Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$41.31 +2.16 (+5.52 %)
(As of 04/24/2019 01:59 PM ET)
Previous Close$39.15
Today's Range$39.00 - $41.43
52-Week Range$30.00 - $55.00
Volume323,462 shs
Average Volume571,787 shs
Market Capitalization$1.70 billion
P/E Ratio142.45
Dividend YieldN/A

Analyst Ratings

Pacira Biosciences (NASDAQ:PCRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Pacira Biosciences in the last 12 months. Their average twelve-month price target is $54.50, suggesting that the stock has a possible upside of 31.93%. The high price target for PCRX is $85.00 and the low price target for PCRX is $33.00. There are currently 3 sell ratings, 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.292.332.472.37
Ratings Breakdown: 3 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $54.50$54.0667$55.1333$48.4118
Price Target Upside: 31.93% upside47.24% upside13.30% upside2.76% upside

Pacira Biosciences (NASDAQ:PCRX) Consensus Price Target History

Price Target History for Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/9/2019Piper Jaffray CompaniesSet Price TargetBuy$55.00LowView Rating Details
3/8/2019WedbushReiterated RatingOutperform$85.00LowView Rating Details
3/8/2019Stifel NicolausReiterated RatingPositive ➝ Sell$33.00LowView Rating Details
3/1/2019BMO Capital MarketsSet Price TargetHold$44.00MediumView Rating Details
3/1/2019CowenReiterated RatingHoldLowView Rating Details
2/12/2019National SecuritiesInitiated CoverageSellMediumView Rating Details
2/1/2019MizuhoDowngradeNeutral ➝ UnderperformHighView Rating Details
11/2/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$45.00 ➝ $50.00LowView Rating Details
11/2/2018Jefferies Financial GroupBoost Price TargetBuy$60.00LowView Rating Details
11/2/2018Royal Bank of CanadaSet Price TargetBuy$60.00HighView Rating Details
11/2/2018HC WainwrightBoost Price TargetBuy$60.00HighView Rating Details
11/1/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Buy$56.00 ➝ $63.00HighView Rating Details
11/1/2018Needham & Company LLCSet Price TargetBuy$60.00HighView Rating Details
10/10/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$46.00 ➝ $48.00HighView Rating Details
10/2/2018Canaccord GenuitySet Price TargetHold ➝ Hold$45.00 ➝ $49.00LowView Rating Details
8/6/2018BarclaysBoost Price TargetOverweight ➝ Buy$40.00 ➝ $50.00LowView Rating Details
5/17/2018OppenheimerReiterated RatingHoldLowView Rating Details
4/8/2018Seaport Global SecuritiesSet Price TargetBuy$48.00MediumView Rating Details
1/2/2018Leerink SwannInitiated CoverageMkt Perform ➝ Market Perform$46.00LowView Rating Details
11/16/2017Janney Montgomery ScottSet Price TargetSell$27.00N/AView Rating Details
9/28/2017Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$41.00MediumView Rating Details
9/7/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformLowView Rating Details
9/6/2017UBS GroupInitiated CoverageMarket PerformMediumView Rating Details
(Data available from 4/24/2017 forward)
This page was last updated on 4/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel